Cross-Correction in HSC Gene Therapy for Metachromatic Leukodystrophy

New England Journal of Medicine · Published 2026-07-29 · DOI 10.1056/nejmc2505002

Authors (17)

Vasco Meneghini, Valeria Calbi, Filippo Casalini, Elisabeth Mangiameli, Francesco Morena, Marco Piccoli, Ilaria Laface, Ilaria Rossomanno, Francesca Ornaghi, Andrea Ghiroldi, Paola M.V. Rancoita, Francesca Fumagalli, Sabata Martino, Luigi Anastasia, Luigi Naldini, Alessandro Aiuti, Angela Gritti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Meneghini, V., Calbi, V., Casalini, F., et al. (2026). Cross-Correction in HSC Gene Therapy for Metachromatic Leukodystrophy. New England Journal of Medicine. https://doi.org/10.1056/nejmc2505002

Related articles

• Health Care–Associated Infections in U.S. Hospitals, 2023 versus 2015 · New England Journal of Medicine · 2026 · Same journal
• Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment · New England Journal of Medicine · 2026 · Same journal
• Mineralocorticoid Receptor Antagonism — FINDing Another Benefit · New England Journal of Medicine · 2026 · Same journal
• Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer · New England Journal of Medicine · 2026 · Same journal
• Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma · New England Journal of Medicine · 2026 · Same journal
• Transdermal Estradiol Patches in Prostate Cancer · New England Journal of Medicine · 2026 · Same journal
• Left Ventricular Unloading in High-Risk PCI · New England Journal of Medicine · 2026 · Same journal
• Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma · New England Journal of Medicine · 2026 · Same journal
• Koebner Phenomenon from Wet Cupping · New England Journal of Medicine · 2026 · Same journal
• More on Digital Twin–Guided Ablation for Ventricular Tachycardia · New England Journal of Medicine · 2026 · Same journal